Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parry, G. J.
Right arrow Articles by Bredesen, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parry, G. J.
Right arrow Articles by Bredesen, D. E.
NEUROLOGY 1985;35:1466
© 1985 American Academy of Neurology

Sensory neuropathy with low-dose pyridoxine

Gareth J. Parry, MB, FRACP and Dale E. Bredesen, MD

From the Department of Neurology, University of California School of Medicine, San Francisco, CA.

We describe 16 patients with neuropathy associated with pyridoxine abuse. The clinical picture of a pure sensory central-peripheral distal axonopathy was consistent. Pyridoxine dose was 0.2 to 5 g/d, and duration of consumption before symptoms was inversely proportional to the daily intake. In all patients with adequate follow-up, improvement followed discontinuation of pyridoxine. The ready availability of up to 1-gram tablets makes it likely that this neuropathy will continue to be seen.

Address correspondence and reprint requests to Dr. Parry, UCSF, Department of Neurology. M-794, San Francisco, CA 94143.

Accepted for publication January 15, 1985.




This article has been cited by other articles:


Home page
 Age AgeingHome page
I. R. Thompson, A. Osei-Lah, and A. Blackburn
Disequilibrium due to a vitamin B6 megadose supplement
Age Ageing, September 1, 2007; 36(5): 597 - 597.
[Full Text] [PDF]

Home page
 EndocrinologyHome page
S.-G. Ren and S. Melmed
Pyridoxal Phosphate Inhibits Pituitary Cell Proliferation and Hormone Secretion
Endocrinology, August 1, 2006; 147(8): 3936 - 3942.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
A. G. Renwick
Toxicology of Micronutrients: Adverse Effects and Uncertainty
J. Nutr., February 1, 2006; 136(2): 493S - 501S.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
A. G. Smith and J. R. Singleton
The Diagnostic Yield of a Standardized Approach to Idiopathic Sensory-Predominant Neuropathy
Arch Intern Med, May 10, 2004; 164(9): 1021 - 1025.
[Abstract] [Full Text] [PDF]

Home page
 Clin. DiabetesHome page
D. L. Trence
Case Study: Peripheral Neuropathy in Diabetes: Is It Diabetic Neuropathy?
Clin. Diabetes, April 1, 2002; 20(2): 103 - 104.
[Full Text] [PDF]

Home page
 BMJHome page
K. M Wyatt, P. W Dimmock, P. W Jones, and P M Shaughn O'Brien
Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review
BMJ, May 22, 1999; 318(7195): 1375 - 1381.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. den Heijer, I. A. Brouwer, G. M. J. Bos, H. J. Blom, N. M. J. van der Put, A. P. Spaans, F. R. Rosendaal, C. M. G. Thomas, H. L. Haak, P. W. Wijermans, et al.
Vitamin Supplementation Reduces Blood Homocysteine Levels : A Controlled Trial in Patients With Venous Thrombosis and Healthy Volunteers
Arterioscler. Thromb. Vasc. Biol., March 1, 1998; 18(3): 356 - 361.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by AAN Enterprises, Inc.